Cancer Screening Guidelines 2026: Breast, Colorectal, Cervical, Lung and Prostate — What US Experts Recommend by Age
Cancer screening means testing people who have no symptoms, so that cancers can be found early, when they are most treatable, or so that pre-cancerous changes can be removed before they become cancer. It is one of the most effective things healthy adults can do for their long-term health, yet many people are unsure which tests they need, at what age, and how often.
The answer depends on your age, sex, family history, smoking history and other risks. This guide summarizes the main US recommendations for five common cancers: breast, colorectal, cervical, lung and prostate. It compares the two sets of recommendations most people hear about, the US Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS), and highlights the 2026 updates. It is a general guide, not a personal plan, so talk to your clinician about what is right for you.
If you or a family member is already in treatment, see our guide to managing treatment side effects: [Cancer Treatment Side Effects: Complete 2026 Management Guide]

Screening at a Glance
Cancer | USPSTF | American Cancer Society | Notes |
Breast | Mammogram every 2 years from age 40 to 74 for average-risk women | Option to start at 40 to 44; annual from 45 to 54; from 55 either every 2 years or continue annually | The USPSTF lowered its start age from 50 to 40 in 2024 |
Colorectal | Screen all adults aged 45 to 75; individualize at 76 to 85 | Start at 45 and continue through 75 | Both agree on 45; the ACS colorectal guideline lists a 2026 update |
Cervical | Age 21 to 29: cytology every 3 years. Age 30 to 65: cytology every 3 years, HPV testing every 5 years, or both every 5 years | Start at 25 with primary HPV testing | HRSA published updated recommendations on January 5, 2026, including options for self-collected HPV tests |
Lung | Annual low-dose CT, ages 50 to 80, with at least a 20 pack-year smoking history, for current smokers or those who quit within 15 years | Similar age and smoking history criteria; details differ slightly | Only for eligible people; not a general test |
Prostate | Shared decision-making about PSA testing at 55 to 69; not routinely at 70 and over | 2026 update: PSA-based screening with informed decision-making every 2 years for average-risk men aged 50 to 69; digital rectal exam not recommended | Guidance differs between organizations |
Recommendations can change, so check the sources linked at the end of this post for the latest versions.
Breast Cancer Screening
Breast cancer is the most common cancer in American women apart from skin cancer. The main screening tool is mammography, an X-ray of the breast.
USPSTF: In 2024, the task force lowered its recommended starting age to 40 and advises a mammogram every 2 years for average-risk women through age 74.
ACS: Women may begin annual screening between 40 and 44, should have annual mammograms from 45 to 54, and from 55 can switch to every 2 years or continue annually. Screening can continue as long as a woman is in good health with a life expectancy of at least 10 years.
Dense breasts: Dense tissue can make mammograms harder to read. It does not automatically mean extra imaging is required under USPSTF guidance, but ask your clinician whether supplemental imaging suits you.
Higher risk: Women with BRCA1 or BRCA2 changes, other inherited gene variants, a strong family history, or past chest radiation may need to start earlier and add breast MRI.
Know how your breasts normally look and feel, and report new lumps, skin changes, nipple changes or discharge promptly, whatever your screening schedule.
Colorectal Cancer Screening
Colorectal cancer is one of the leading causes of cancer death, and it is also one of the most preventable, because screening can find and remove polyps before they become cancer.
Both the ACS and the USPSTF recommend starting screening at age 45 for average-risk adults and continuing through 75. For ages 76 to 85, the decision is individualized, and screening is generally not recommended after 85.
The ACS lists a 2026 update to its colorectal guideline that adds a stool RNA test and provides guidance on blood-based tests. Ask your clinician how these newer options compare with established tests.
Test | How it works | Typical interval |
Colonoscopy | A camera examines the whole colon; polyps can be removed during the test | Every 10 years if normal |
FIT (fecal immunochemical test) | Home stool test for hidden blood | Every year |
Stool DNA-FIT test | Home stool test for blood and DNA changes | Every 1 to 3 years |
CT colonography | A scan of the colon | Every 5 years |
Flexible sigmoidoscopy | A camera examines the lower colon | Every 5 years |
Any positive stool test needs a follow-up colonoscopy. Symptoms such as blood in the stool, persistent change in bowel habits, unexplained weight loss or iron-deficiency anemia need medical evaluation at any age. People with a close relative who had colorectal cancer, inflammatory bowel disease, or an inherited syndrome such as Lynch syndrome often need to start earlier or be screened more often.
Cervical Cancer Screening
Almost all cervical cancers are caused by persistent infection with high-risk strains of human papillomavirus (HPV). Screening finds HPV or the cell changes it causes, so they can be treated early.
USPSTF: Ages 21 to 29, a Pap test (cytology) every 3 years. Ages 30 to 65, a Pap test every 3 years, an HPV test every 5 years, or both together every 5 years. Screening can stop at 65 after adequate prior screening.
ACS: Start at 25 with primary HPV testing.
2026 update: The Health Resources and Services Administration (HRSA) published updated cervical screening recommendations on January 5, 2026. State health departments have described the update, including the use of self-collected HPV tests in some situations. If a self-collected HPV test is negative, the next screening is due in 3 years, per the ACS.
HPV vaccination lowers the risk of the cancers caused by the virus, but it does not replace screening.
Report bleeding after sex, between periods or after menopause, and unusual discharge or pelvic pain, regardless of screening status.
Lung Cancer Screening
Lung cancer screening is different from the other four: it is only for people at high risk, because the test, a low-dose CT scan, is recommended for people who have smoked heavily.
The USPSTF recommends annual low-dose CT scans for adults aged 50 to 80 with at least a 20 pack-year smoking history (packs per day multiplied by years smoked) who currently smoke or quit within the past 15 years.
Chest X-rays and sputum tests are not recommended for screening.
People who are eligible should discuss the benefits and risks, including false alarms, with a clinician and should also be offered help to quit smoking.
Quitting smoking is the single most important step to lower lung cancer risk. Our guide to a prescription option for smoking cessation: [Bupropion (Wellbutrin/Zyban) Complete 2026 Guide]
For people diagnosed with a certain type of lung cancer, targeted drugs exist; see: [Tagrisso vs Osimertinib: Name, Strength, Uses and Cost Guide]
Report a cough that does not go away, coughing up blood, unexplained weight loss, chest pain or repeated chest infections.
Prostate Cancer Screening
Prostate cancer screening is the most debated of the five, because PSA tests can detect slow-growing cancers that might never cause harm, which can lead to unnecessary treatment.
ACS 2026: The American Cancer Society's updated guideline recommends PSA-based screening with informed decision-making every 2 years for average-risk men aged 50 to 69, with different advice for higher-risk men. It does not recommend digital rectal examination for screening.
USPSTF (2018): Shared decision-making for men aged 55 to 69, and no routine screening at 70 and over.
Higher risk: Black men and men with a close relative who had prostate cancer are at higher risk and may be advised to discuss screening earlier.
Informed decision-making means discussing the benefits (possibly lowering the chance of dying from prostate cancer) and the harms (false positives, biopsies, overdiagnosis and side effects of treatment) before testing.
An enlarged prostate (BPH) is common and not cancer, but it can also raise PSA. See: [Tamsulosin (Flomax) for BPH: Complete 2026 Guide]
Who Is at Higher Risk?
Factor | Why it matters | What to do |
Close relative with the same cancer | Raises your own risk, sometimes sharply | Ask whether to start earlier or screen more often |
Known inherited gene changes (BRCA1, BRCA2, Lynch syndrome and others) | Much higher risk of certain cancers | Specialist-guided screening plans, often including MRI or colonoscopy |
Heavy smoking history | Strongly raises lung cancer risk | Check eligibility for low-dose CT and get help to quit |
Past chest radiation (for example, for lymphoma) | Raises breast cancer risk | Earlier breast screening, often with MRI |
Inflammatory bowel disease or previous polyps | Raises colorectal cancer risk | More frequent colonoscopy |
Weakened immune system or HIV | Raises risk of cervical and other cancers | Closer cervical screening |
Being Black (prostate) | Higher prostate cancer incidence and mortality | Discuss screening earlier |
Having liver disease from hepatitis B or C also raises liver cancer risk, and people who have been treated should ask about ongoing monitoring. See: [Hepatitis C: Direct-Acting Antivirals and Cure Guide]
Cost and Coverage
Many health plans must cover certain recommended screenings, including mammograms, colorectal screening and cervical screening, without charging you a copayment, and Medicare covers many of them. Coverage rules vary by plan, test and age, and a follow-up test after a positive screen may be billed differently. Check with your insurer, and ask your clinic about low-cost programs if you are uninsured or underinsured.
Practical Steps
1. Find out your family history. Ask relatives about cancers, the type and the age at diagnosis.
2. Make a list of which screenings you are due for, using the table above.
3. Book the tests and ask the clinic to note them in your record.
4. Do not ignore symptoms because a recent screening was normal.
5. Keep up with healthy habits: not smoking, a healthy weight, regular activity, limited alcohol, sun protection and vaccination against HPV and hepatitis B where recommended.
6. If you are told you need follow-up testing, do not delay it.
When to See a Doctor Without Waiting for Screening
See a clinician promptly for a new lump, bleeding that is unexplained, a sore that does not heal, a mole that changes, a persistent cough or hoarseness, trouble swallowing, blood in the stool or urine, unexplained weight loss, persistent pain, or fevers and night sweats. Most of these have benign causes, but they should be checked.
The ACS prostate cancer screening guideline for 2026 is available at: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70112
The American Cancer Society screening guideline overview is available at: https://www.cancer.org/health-care-professionals/american-cancer-society-prevention-early-detection-guidelines/overview.html
A state health department summary of USPSTF recommendations and the January 2026 HRSA cervical update is available at: https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/publichealth4all/USPSTF-recommendations.aspx
Frequently Asked Questions
At what age should I start cancer screenings?
For average-risk adults, cervical screening starts at 21 under the USPSTF (25 under the ACS), mammography at 40 under the USPSTF (the ACS offers it at 40 to 44 and recommends it annually from 45), and colorectal screening at 45 under both groups. Lung screening is for adults aged 50 to 80 with a heavy smoking history, and prostate screening is a shared decision starting around 50 to 55 depending on the guideline.
What is new in cancer screening in 2026?
Several updates were published: HRSA released updated cervical cancer screening recommendations on January 5, 2026, which include self-collected HPV testing options. The American Cancer Society updated its prostate cancer guideline, recommending PSA-based screening with informed decision-making every 2 years for average-risk men aged 50 to 69. Its colorectal screening guideline lists a 2026 update that adds a stool RNA test and guidance on blood-based tests.
How often do I need a colonoscopy?
For average-risk adults with a normal colonoscopy, the usual interval is every 10 years. Other options include a yearly FIT stool test, a stool DNA test every 1 to 3 years, CT colonography every 5 years, or flexible sigmoidoscopy every 5 years. People with polyps, a family history, or inflammatory bowel disease may need colonoscopy more often.
Who should have a lung cancer screening CT?
The USPSTF recommends an annual low-dose CT scan for adults aged 50 to 80 who have at least a 20 pack-year smoking history and currently smoke or quit within the past 15 years. It is not recommended for people who are not at high risk, and chest X-rays are not a substitute.
Should I get a PSA test for prostate cancer?
It is a personal decision to make with your clinician. The American Cancer Society's 2026 guideline recommends PSA-based screening with informed decision-making every 2 years for average-risk men aged 50 to 69, and the USPSTF recommends shared decision-making for men 55 to 69 and no routine screening at 70 and over. Black men and men with a close relative with prostate cancer are at higher risk and may wish to discuss screening earlier.





Comments